FHIT gene sequence variants and reduced fhit protein expression in glioblastoma multiforme

Cellular and Molecular Neurobiology

Volumn 30, Issue 2, 2010, Pages 301-307

  Cecener, Gulsah ^a   Tunca, Berrin ^a   Egeli, Unal ^a   Bekar, Ahmet ^a   Guler, Gulnur ^b   Tolunay, Sahsine ^a   Aksoy, Kaya ^c  

^a ULUDAG UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c Acibadem Hospital   (Turkey)

Author keywords

FHIT gene; Glioblastoma multiforme; IHC; Sequence alterations; SSCP

Indexed keywords

FRAGILE HISTIDINE TRIAD PROTEIN; ACID ANHYDRIDE HYDROLASE; TUMOR PROTEIN;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SINGLE STRAND CONFORMATION POLYMORPHISM; BRAIN TUMOR; GENETICS; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

ACID ANHYDRIDE HYDROLASES; ADULT; AGED; BASE SEQUENCE; BRAIN NEOPLASMS; FEMALE; GENETIC VARIATION; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SEQUENCE ANALYSIS, DNA;

EID: 77952095741     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10571-009-9452-9     Document Type: Article

References (38)

1. M Ahmadian II Wistuba KM Fong, et al. 1997 Analysis of the FHIT Gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands Cancer Res 57 3664 3668 1:CAS:528:DyaK2sXlvFentrw%3D 9288768
2. FG Barker MD Prados SM Chang, et al. 1996 Radiation response and survival time in patients with glioblastoma multiforme J Neurosurg 84 442 448 10.3171/jns.1996.84.3.0442 8609556
3. TT Batchelor RA Betensky JM Esposito LD Pham MV Dorfman N Piscatelli S Jhung D Rhee DN Louis 2004 Age-dependent prognostic effects of genetic alterations in glioblastoma Clin Cancer Res 10 228 233 10.1158/1078-0432.CCR- 0841-3 1:CAS:528:DC%2BD2cXkvF2mtQ%3D%3D 14734474 (Pubitemid 38114184)
4. A Bekar G Cecener B Tunca G Guler U Egeli S Tolunay 2007 Investigation of mutations and expression of the FHIT gene in Turkish patients with brain metastases derived from non-small cell lung cancer Tumori 93 604 607 1:CAS:528:DC%2BD1cXitVOiurc%3D 18338497
5. G Cecener Ü Egeli İ Taşdelen B Tunca H Duman A KIzIl 1998 Common fragile sites expression and genetic predisposition to breast cancer Teratog Carcinog Mutagen 18 279 291 10.1002/(SICI)1520-6866(1998)18:6<279:: AID-TCM2>3.0.CO;2-U 1:CAS:528:DyaK1MXhsFWmtL8%3D 10052563 (Pubitemid 29102463)
6. G Cecener U Egeli B Tunca I Tasdelen S Tolunay N Bilgel 2007 Importance of novel sequence alterations in the FHIT gene on formation of breast cancer Tumori 93 597 603 1:CAS:528:DC%2BD1cXitVOiurk%3D 18338496
7. VP Collins 2004 Brain tumours: classification and genes J Neurol Neurosurg Psychiatry 75 2 11 10.1136/jnnp.2004.040337 (Pubitemid 41652835)
8. WJ Curran Jr CB Scott J Horton, et al. 1993 Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials J Natl Cancer Inst 85 704 710 10.1093/jnci/85.9.704 8478956
9. T Druck P Hadaczek TB Fu, et al. 1997 Structure and expression of the human FHIT gene in normal and tumor cells Cancer Res 57 504 512 1:CAS:528:DyaK2sXhtVKms7w%3D 9012482
10. Ü Egeli M Karadaǧ B Tunca N ÖzyardImcI 1997 The expression of common fragile sites and genetic predisposition to squamous cell lung cancers Cancer Genet Cytogenet 95 153 158 10.1016/S0165-4608(96)00215-4 1:STN:280:DyaK2szht1GqsA%3D%3D 9169033 (Pubitemid 27217123)
11. U Egeli L Özkan B Tunca S Kahraman G Cecener E Ergül K Engin 2000 The relationship between genetic susceptibility to head and neck cancer with the expression of common fragile sites Head Neck 22 591 598 10.1002/1097-0347(200009)22:6<591::AID-HED8>3.0.CO;2-C 1:STN:280:DC%2BD3M%2FhsFCnsg%3D%3D 10941161 (Pubitemid 30663075)
12. KM Fong EJ Biesterveld A Virmania, et al. 1997 FHIT and FRA3B 3p14.2 Allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer related FHIT cDNA splicing aberrations Cancer Res 57 2256 2267 1:CAS:528:DyaK2sXjslKitLs%3D 9187130
13. S Frank J Muller J Plaschke M Hahn J Hampl M Hampl S Pistorius G Schackert HK Schackert 1997 The putative tumor suppressor gene FHIT at 3p14.2 is rarely affected by loss of heterozygosity in primary human brain tumors Cancer Res 57 2638 2641 1:CAS:528:DyaK2sXkt12qtb8%3D 9205070
14. A Gemma K Hagiwarn Y Ke LM Burke MA Khan M Nagashima WP Bennett CC Harris 1997 FHIT mutations in human primary gastric cancer Cancer Res 57 1435 1437 1:CAS:528:DyaK2sXis12lsrs%3D 9108441
15. G Guler A Uner N Guler SY Han D Iliopoulos WW Hauck P McCue K Huebner 2004 The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma Cancer 100 1605 1614 10.1002/cncr.20137 1:CAS:528: DC%2BD2cXjvFygt7c%3D 15073846 (Pubitemid 38456335)
16. C Hill SB Hunter DJ Brat 2003 Genetic markers in glioblastoma: prognostic significance and future therapeutic implications Adv Anat Pathol 10 212 217 10.1097/00125480-200307000-00004 1:CAS:528:DC%2BD3sXovFGltbw%3D 12826827
17. K Huebner C Croce 2001 FRA3B and other common fragile sites: the weakest links Nat Rev Cancer 1 214 221 10.1038/35106058 1:CAS:528:DC%2BD38XlvF2qtrs%3D 11902576
18. K Ichimura H Ohgaki P Kleihues VP Collins 2004 Molecular pathogenesis of astrocytic tumours J Neurooncol 70 137 160 10.1007/s11060-004-2747-2 15674475 (Pubitemid 39549305)
19. D Iliopoulos G Guler SY Han T Druck M Ottey KA McCorkell K Huebner 2006 Roles of FHIT and WWOX fragile genes in cancer Cancer Lett 232 27 36 10.1016/j.canlet.2005.06.048 1:CAS:528:DC%2BD28XjsF2jsw%3D%3D 16225988 (Pubitemid 43053931)
20. M Jansen PC de Witt Hamer AN Witmer D Troost CJ van Noorden 2004 Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas Brain Res 45 143 163 10.1016/j.brainresrev.2004.03.001 1:CAS:528:DC%2BD2cXltVChu7s%3D (Pubitemid 38802868)
21. K Kannan J Krishnamurthy J Feng T Nakajima N Tsuchida G Shanmugam 2000 Mutation profile of the p53, FHIT, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas Int J Oncol 17 1031 1035 1:CAS:528:DC%2BD3cXotVKrsr8%3D 11029509
22. M Karadaǧ B Tunca G Cecener Ü Egeli N ÖzyardImcI E Ege O Gözü 2002 Chromosomal fragile sites and relationship between genetic predisposition to small cell lung cancer Teratog Carcinog Mutagen 22 31 40 10.1002/tcm.1036 11754385 (Pubitemid 34024286)
23. P Kleihues PC Burger BW Scheithauer 1993 The new WHO classification of brain tumours Brain Pathol 3 255 268 10.1111/j.1750-3639.1993.tb00752.x 1:STN:280:DyaK2c7it12rsw%3D%3D 8293185
24. MM Le Beau H Drabkin TW Glover R Gemmill FV Rassool TW McKeithan DI Smith 1998 An FHIT tumor suppressor gene? Genes Chromosomes Cancer 21 281 289 10.1002/(SICI)1098-2264(199804)21:4<281::AID-GCC1>3.0.CO;2-V 9559339 (Pubitemid 28165035)
25. E Mathe M Olivier S Kato C Ishioka P Hainaut SV Tavtigian 2006 Computational approaches for predicting the biological effect of p53 missense mutations: a comparison of three sequence analysis based methods Nucleic Acids Res 34 1317 1325 10.1093/nar/gkj518 1:CAS:528:DC%2BD28XjtFSrsrs%3D 16522644
26. H Ohgaki P Kleihues 2005 Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas J Neuropathol Exp Neurol 64 479 489 1:CAS:528:DC%2BD2MXlvVSgsbg%3D 15977639
27. H Ohgaki P Dessen B Jourde, et al. 2004 Genetic pathways to glioblastoma: a population-based study Cancer Res 64 6892 6899 10.1158/0008-5472.CAN-04-1337 1:CAS:528:DC%2BD2cXotFalsrc%3D 15466178 (Pubitemid 39330996)
28. M Ohta H Inoue MG Cotticelli, et al. 1996 The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma associated t(3;8) breakpoint, is abnormal in digestive tract cancers Cell 84 587 597 10.1016/S0092-8674(00) 81034-X 1:CAS:528:DyaK28Xhtlemsrg%3D 8598045 (Pubitemid 26071739)
29. Y Pekarsky N Zanesi A Palamarchuk K Huebner CM Croce 2002 FHIT: from gene discovery to cancer treatment and prevention Lancet Oncol 3 748 754 10.1016/S1470-2045(02)00931-2 1:CAS:528:DC%2BD38XptlSqsLY%3D 12473516 (Pubitemid 35446744)
30. G Sozzi M Veronese M Negrini, et al. 1996 The FHIT Gene At 3p14.2 is abnormal in lung cancer Cell 85 17 26 10.1016/S0092-8674(00)81078-8 1:CAS:528:DyaK28Xit1aksb4%3D 8620533 (Pubitemid 26116803)
31. TC Tsai HM Yang YL Wu CW Chi MD Chou LS Lee TJ Chang 1999 Abnormal transcripts of FHIT gene in Chinese brain tumors Oncol Rep 6 345 348 1:CAS:528:DyaK1MXhs12mtr0%3D 10023002
32. B Tunca Ü Egeli A Zorluoǧlu T YIlmazlar Ö Yerci A KIzIl 2000 The expression frequency of common fragile sites and genetic predisposition to colon cancer Cancer Genet Cytogenet 119 139 145 10.1016/S0165-4608(99)00228- 9 1:CAS:528:DC%2BD3cXktV2qs70%3D 10867150 (Pubitemid 30365293)
33. B Tunca G Cecener C Gebitekin U Egeli B Ediz I Ercan 2002 Investigation of genetic susceptibility to non-small cell lung cancer by fragile site expression Teratog Carcinog Mutagen 22 205 215 10.1002/tcm.10014 1:CAS:528:DC%2BD38XjsFamtrc%3D 11948631 (Pubitemid 34437648)
34. B Tunca A Bekar G Cecener U Egeli O Vatan S Tolunay H Kocaeli K Aksoy 2007 Impact of novel PTEN mutations in Turkish patients with glioblastoma multiforme J Neurooncol 82 263 269 10.1007/s11060-006-9293-z 1:CAS:528:DC%2BD2sXlvF2ju7Y%3D 17151929 (Pubitemid 46614388)
35. J Wang PJ Smith AR Krainer MQ Zang 2005 Distribution of SR protein exonic splicing enhancer motifs human protein-coding genes Nucleic Acids Res 33 5053 5062 10.1093/nar/gki810 1:CAS:528:DC%2BD2MXhtVKhsrzM 16147989 (Pubitemid 41487813)
36. Watson JD, Hopkins NH (1987) The genetic code. In: Watson JD, Hopkins NH (eds) Molecular biology of the gene, 4th edn. The Benjamin/Cummings Publishing Company, California, p 444
37. K Yoshino T Enomoto T Nakamura R Nakashima H Wada J Saitoh K Noda Y Murata 1998 Aberrant FHIT transcripts in squamous cell carcinoma of the uterine cervix Int J Cancer 76 176 181 10.1002/(SICI)1097-0215(19980413)76:2<176:: AID-IJC2>3.0.CO;2-U 1:STN:280:DyaK1c7ps12htQ%3D%3D 9537577 (Pubitemid 28180369)
38. XR Zhao LC Kang YS Zhou, et al. 2003 Mutations of fragile histidine triad gene in Peutz-Jeghers syndrome and canceration Ai Zheng 22 50 54 1:CAS:528:DC%2BD2cXptlyju78%3D 12561436